TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market

TransMedics Group (TMDX) Stock Forecast & Price Target

248 Followers
See the Price Targets and Ratings of:

TMDX Analyst Ratings

Moderate Buy
3Ratings
2 Buy
1 Hold
0 Sell
Based on 3 analysts giving stock ratings to
TransMedics
Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TMDX Stock 12 Months Forecast

Average Price Target

$59.33
▲(2.77% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for TransMedics Group in the last 3 months. The average price target is $59.33 with a high forecast of $63.00 and a low forecast of $54.00. The average price target represents a 2.77% change from the last price of $57.73.
Highest Price Target$63.00Average Price Target$59.33Lowest Price Target$54.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Oppenheimer
$45.00
Buy
-22.05%
Downside
Reiterated
Oppenheimer Maintains Outperform on TransMedics Group, Raises Price Target to $45
Cowen & Co.
$50.00
Buy
-13.39%
Downside
Reiterated
TransMedics price target raised to $50 from $45 at CowenTransMedics price target raised to $50 from $45 at Cowen
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

TMDX Financial Forecast

TMDX Earnings Forecast
Next quarter’s earnings estimate for TMDX is -$0.30 with a range of -$0.39 to -$0.23. The previous quarter’s EPS was -$0.25. TMDX beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year TMDX has Underperformed its overall industry.
Next quarter’s earnings estimate for TMDX is -$0.30 with a range of -$0.39 to -$0.23. The previous quarter’s EPS was -$0.25. TMDX beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year TMDX has Underperformed its overall industry.
TMDX Sales Forecast
Next quarter’s sales forecast for TMDX is $24.45M with a range of $22.11M to $27.00M. The previous quarter’s sales results were $25.68M. TMDX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year TMDX has Outperformed its overall industry.
Next quarter’s sales forecast for TMDX is $24.45M with a range of $22.11M to $27.00M. The previous quarter’s sales results were $25.68M. TMDX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year TMDX has Outperformed its overall industry.
TMDX Analyst Recommendation Trends
In the current month, TMDX has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The TMDX average analyst price target in the past 3 months is $59.33
In the current month, TMDX has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The TMDX average analyst price target in the past 3 months is $59.33

TMDX Stock Forecast FAQ

What is TMDX’s average 12-month price target, according to analysts?
Based on analyst ratings, TransMedics Group’s 12-month average price target is $59.33.
    What is TMDX’s upside potential, based on the analysts’ average price target?
    TransMedics Group has 2.77% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TMDX a Buy, Sell or Hold?
          TransMedics Group has a conensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
            What is TransMedics Group’s price target?
            The average price target for TransMedics Group is $59.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $63.00 ,the lowest forecast is $54.00. The average price target represents 2.77% Increase from the current price of $57.73.
              What do analysts say about TransMedics Group?
              TransMedics Group’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis